# Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome

> **NCT01670357** · PHASE2 · COMPLETED · sponsor: **Dong-A ST Co., Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DRUG:** DA-6034 3%
- **DRUG:** DA-6034 5%
- **DRUG:** DA-6034 Placebo

## Key facts

- **NCT ID:** NCT01670357
- **Lead sponsor:** Dong-A ST Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2014-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01670357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01670357, "Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01670357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*